AAVB-039 advances gene therapy for Stargardt disease, aiming for innovative treatments for inherited retinal disorders.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This includes, but ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Plus Nanoscope Therapeutics applies for FDA approval and Metrocrest Hospital Authority's nonprofit grants.

US FDA accepts resubmitted NDA of Aldeyra Therapeutics for review of topical ocular reproxalap to treat dry eye disease: Lexington, Massachusetts Saturday, July 19, 2025, 13:00 Hr ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for topical ...

One study reported 8 live births from 22 women with pathogenic mtDNA variants who underwent mitochondrial donation through ...

The pace of quarterly reports is stiffening and in the main, like a lamington, the news is easy to digest for ASX biotech investors.

The uncertainty around tariffs and trade production measures has muted economic growth. President Trump has once again ...

High-profile news coverage that eLife papers generated in May 2025, including The Scientist, The Times of India, and IFL Science.

Myeloma Trial Results Spark Talk of 'Potential Cure' — One-third of patients alive and progression-free 5 or more years after a single infusion ...